JLK Inc
KOSDAQ:322510
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (22.5), the stock would be worth ₩-1 093.41 (115% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -154.5 | ₩7 500 |
0%
|
| Industry Average | 22.5 | ₩-1 093.41 |
-115%
|
| Country Average | 15.1 | ₩-731.17 |
-110%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
J
|
JLK Inc
KOSDAQ:322510
|
188.9B KRW | -154.5 | -17.2 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 88.6 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 36.2 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
25.9B USD | 18.2 | 27.7 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.1B AUD | 117.4 | 59.6 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 23.6 | 20.6 | |
| SE |
|
Sectra AB
STO:SECT B
|
49.6B SEK | 79.2 | 91.5 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.8B USD | 10.4 | 42.2 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 14.3 | 18.3 | |
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
267.3B INR | -189.8 | 40.3 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
18.9B CNY | 79 | -61.4 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 8.1 |
| Median | 15.1 |
| 70th Percentile | 28.4 |
| Max | 21 200 |
Other Multiples
JLK Inc
Glance View
JLK, Inc. develops AI based data-driven diagnostic system that detects brain disease. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2019-12-11. The firm develops software including AI medical analysis solutions, AI industry and security analysis solutions and others. Medical diagnostic platforms consist of AI medical systems, AI quantitative analysis platforms, AI remote platforms, AI medical diagnostic platforms, among others.
